Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-08-03 Purchase |
2021-08-03 5:16 pm |
Omega Therapeutics Inc. | OMGA | Sawhney Roger Chief Financial Officer |
2,941 | $17 | $49,997 | 2,941 (Direct) |
View |
| 2021-07-30 Purchase |
2021-08-03 5:16 pm |
Omega Therapeutics Inc. | OMGA | Invus Public Equities L.P. Artal International S.C.A. Artal International Management S.A. Artal Group S.A. Westend S.A. Wittouck Amaury Stichting Administratiekantoor Westend Artal Treasury Ltd Invus Public Equities Advisors LLC 10% Owner |
950,000 | $16.93 | $16,085,343 | 2,273,530 (Direct) |
View |
| 2021-08-03 Purchase |
2021-08-03 5:15 pm |
Omega Therapeutics Inc. | OMGA | BERRY DAVID A Director |
53,082 | $17 | $902,394 | 53,082 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-08-03 Conversion |
2021-08-03 5:16 pm |
N/A N/A |
Omega Therapeutics Inc. | OMGA | Invus Public Equities L.P. Artal International S.C.A. Artal International Management S.A. Artal Group S.A. Westend S.A. Wittouck Amaury Stichting Administratiekantoor Westend Artal Treasury Ltd Invus Public Equities Advisors LLC 10% Owner |
6,323,530 | $0 | 2,273,530 (Direct) |
View |
| 2021-07-29 Option Award |
2021-07-30 5:05 pm |
N/A 2031-07-28 |
Omega Therapeutics Inc. | OMGA | AFEYAN NOUBAR Director 10% Owner |
19,852 | $0 | 19,852 (Direct) |
View |
| 2021-07-29 Option Award |
2021-07-30 5:05 pm |
N/A 2031-07-28 |
Omega Therapeutics Inc. | OMGA | BESHAR LUKE M Director |
52,941 | $0 | 52,941 (Direct) |
View |
| 2021-07-29 Option Award |
2021-07-30 5:05 pm |
N/A 2031-07-28 |
Omega Therapeutics Inc. | OMGA | BERRY DAVID A Director |
19,852 | $0 | 19,852 (Direct) |
View |
Ownership |
2021-07-29 9:05 pm |
N/A N/A |
Omega Therapeutics Inc. | OMGA | Flagship Pioneering Inc. Flagship Ventures Fund V General Partner LLC Flagship V VentureLabs Rx Fund L.P. Flagship Ventures Fund V L.P. Flagship VentureLabs V Manager LLC Flagship VentureLabs V LLC Director 10% Owner |
0 | $0 | 24,725,800 (Indirect) |
View |
Ownership |
2021-07-29 9:04 pm |
N/A 2030-01-25 |
Omega Therapeutics Inc. | OMGA | MENDLEIN JOHN Director |
0 | $0 | 221,360 (Direct) |
View |
Ownership |
2021-07-29 9:04 pm |
N/A 2031-03-28 |
Omega Therapeutics Inc. | OMGA | Levy Elliott M. Director |
0 | $0 | 52,941 (Direct) |
View |
Ownership |
2021-07-29 9:04 pm |
N/A N/A |
Omega Therapeutics Inc. | OMGA | Young Richard A Director 10% Owner |
0 | $0 | 794,118 (Direct) |
View |
Ownership |
2021-07-29 9:03 pm |
N/A 2030-09-29 |
Omega Therapeutics Inc. | OMGA | Sawhney Roger Chief Financial Officer |
0 | $0 | 499,681 (Direct) |
View |
Ownership |
2021-07-29 9:02 pm |
N/A N/A |
Omega Therapeutics Inc. | OMGA | Karande Mahesh President and CEO 10% Owner |
0 | $0 | 2,265,752 (Direct) |
View |
Ownership |
2021-07-29 9:01 pm |
N/A N/A |
Omega Therapeutics Inc. | OMGA | Jaenisch Rudolf 10% Owner |
0 | $0 | 794,118 (Direct) |
View |
Ownership |
2021-07-29 9:01 pm |
N/A N/A |
Omega Therapeutics Inc. | OMGA | McCauley Thomas Chief Scientific Officer |
0 | $0 | 481,513 (Direct) |
View |
Ownership |
2021-07-29 9:01 pm |
N/A 2029-09-16 |
Omega Therapeutics Inc. | OMGA | Szela Mary T Director |
0 | $0 | 83,826 (Direct) |
View |
Ownership |
2021-07-29 9:01 pm |
N/A N/A |
Omega Therapeutics Inc. | OMGA | Invus Public Equities L.P. Artal Treasury Ltd Artal International S.C.A. Artal International Management S.A. Artal Group S.A. Westend S.A. Wittouck Amaury Stichting Administratiekantoor Westend Invus Public Equities Advisors LLC 10% Owner |
0 | $0 | 1,323,530 (Direct) |
View |
Ownership |
2021-07-29 9:00 pm |
N/A N/A |
Omega Therapeutics Inc. | OMGA | Flagship Pioneering Inc. Flagship Pioneering Fund VI General Partner LLC Flagship Pioneering Fund VI L.P. Flagship Pioneering Special Opportunities Fund II L.P. Flagship Pioneering Special Opportunities Fund II General Partner LLC Nutritional Health LTP Fund L.P. Nutritional Health LTP Fund General Partner LLC FPN General Partner LLC FPN L.P. AFEYAN NOUBAR Director 10% Owner |
0 | $0 | 24,725,800 (Indirect) |
View |